Shares of Sotera Health Company (SHC) are surging 7.48% in pre-market trading on Thursday following the company's impressive first-quarter 2025 earnings report. The healthcare services provider delivered results that surpassed analysts' expectations on multiple fronts.

Sotera Health reported adjusted earnings per share of $0.14, beating the consensus estimate of $0.12. Revenue for the quarter came in at $254.5 million, exceeding Wall Street's projection of $245.8 million. The company's Adjusted EBITDA of $121.8 million also outperformed expectations, with a margin of 47.9% that was notably higher than anticipated.

Adding to investor optimism, Sotera Health reaffirmed its full-year 2025 outlook. The company continues to project net revenue growth of 4.0% to 6.0% and Adjusted EBITDA growth of 4.5% to 6.5%, both on a constant currency basis. Chairman and CEO Michael B. Petras, Jr. expressed satisfaction with the results, stating, "We are pleased to report a solid start to the year with mid-single digit revenue growth and strong double digit Adjusted EBITDA growth, on a constant currency basis." The combination of strong quarterly performance and maintained guidance appears to be driving the stock's significant pre-market rally.